2023
Grove, J. I., Stephens, C., Lucena, M. I., Andrade, R. J., Weber, S., Gerbes, A., . . . TransBioLine consortium. (2023). Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study.. Diagnostic and prognostic research, 7(1), 18. doi:10.1186/s41512-023-00155-zDOI: 10.1186/s41512-023-00155-z
In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells (Journal article)
Pridgeon, C. S., Forootan, S. S., Zhang, F., Harper, N., Palmer, D., Weightmann, R., . . . Goldring, C. E. P. (2023). In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells. JOURNAL OF STEM CELLS & REGENERATIVE MEDICINE, 19(1), P2-P12. doi:10.46582/jsrm.1901002DOI: 10.46582/jsrm.1901002
2021
Systems analysis of miRNA biomarkers to inform drug safety (Journal article)
Schofield, A. L., Brown, J. P., Brown, J., Wilczynska, A., Bell, C., Glaab, W. E., . . . Goldring, C. (2021). Systems analysis of miRNA biomarkers to inform drug safety. ARCHIVES OF TOXICOLOGY, 95(11), 3475-3495. doi:10.1007/s00204-021-03150-9DOI: 10.1007/s00204-021-03150-9
Vaselli, N. M., Setiabudi, W., Subramaniam, K., Adams, E. R., Turtle, L., Iturriza-Gomara, M., . . . Hungerford, D. (2021). Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK. BMC INFECTIOUS DISEASES, 21(1). doi:10.1186/s12879-021-06443-7DOI: 10.1186/s12879-021-06443-7
Chan, B. K. Y., Elmasry, M., Forootan, S. S., Russomanno, G., Bunday, T. M., Zhang, F., . . . Copple, I. M. (2021). Pharmacological Activation of Nrf2 Enhances Functional Liver Regeneration. HEPATOLOGY, 74(2), 973-986. doi:10.1002/hep.31859DOI: 10.1002/hep.31859
Setiabudi, W., Hungerford, D., Subramaniam, K., Vaselli, N. M., Shaw, V. E., Wilton, M., . . . French, N. (2021). Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol. BMJ Open, 11(3), e048317. doi:10.1136/bmjopen-2020-048317DOI: 10.1136/bmjopen-2020-048317
2020
Al-Jameel, W., Gou, X., Forootan, S. S., Al Fayi, M. S., Rudland, P. S., Forootan, F. S., . . . Ke, Y. (2020). Erratum: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 (Oncotarget (2017) 8 (31041-31056)). Oncotarget, 11(31), 3025. doi:10.18632/oncotarget.16055DOI: 10.18632/oncotarget.16055
Yousefnia, S., Seyed Forootan, F., Seyed Forootan, S., Nasr Esfahani, M. H., Gure, A. O., & Ghaedi, K. (2020). Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.. Frontiers in Oncology, 10. doi:10.3389/fonc.2020.00452DOI: 10.3389/fonc.2020.00452
2017
Forootan, S. S., Mutter, F. E., Kipar, A., Iwawaki, T., Francis, B., Goldring, C. E., . . . Copple, I. M. (2017). Real-time in vivo imaging reveals localised Nrf2 stress responses associated with direct and metabolism-dependent drug toxicity. SCIENTIFIC REPORTS, 7, 11 pages. doi:10.1038/s41598-017-16491-2DOI: 10.1038/s41598-017-16491-2
Clarke, J. I., Forootan, S. S., Lea, J. D., Howell, L. S., Rodriguez, J. M., Kipar, A., . . . Antoine, D. J. (2017). Circulating levels of miR-122 increase post-mortem, particularly following lethal dosing with pentobarbital sodium: implications for pre-clinical liver injury studies. TOXICOLOGY RESEARCH, 6(4), 406-411. doi:10.1039/c6tx00442cDOI: 10.1039/c6tx00442c
Al-Jameel, W., Gou, X., Forootan, S. S., Al Fayi, M. S., Rudland, P. S., Forootan, F. S., . . . Ke, Y. (n.d.). Inhibitor SBFI26 suppresses the malignant progression ofcastration-resistant PC3-M cells by competitively binding tooncogenic FABP5. Oncotarget, 8(19), 31041-31056. doi:10.18632/oncotarget.16055DOI: 10.18632/oncotarget.16055
2016
Increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance (Journal article)
AL Fayi, M. S., Gou, X., Forootan, S., Al-Jameel, W., Zhang, J., Bao, Z., . . . Ke, Y. (2016). Increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance. Oncotarget, 7(50), 82783-82797. doi:10.18632/oncotarget.12635DOI: 10.18632/oncotarget.12635
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter (Journal article)
Forootan, F. S., Forootan, S. S., Gou, X., Yang, J., Liu, B., Chen, D., . . . Ke, Y. (2016). Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter. Oncotarget, 7(8), 9322-9339. doi:10.18632/oncotarget.6975DOI: 10.18632/oncotarget.6975
Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications (Journal article)
Forootan, S. S., Butler, J. M., Gardener, D., Baird, A. E., Dodson, A., Darby, A., . . . Gosden, C. M. (2016). Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications. INTERNATIONAL JOURNAL OF ONCOLOGY, 48(1), 130-144. doi:10.3892/ijo.2015.3222DOI: 10.3892/ijo.2015.3222
2014
Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer. (Journal article)
Chen, D., Seyed Forootan, S., Gosney, J. R., Forootan, F. S., & Ke, Y. (2014). Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer.. Genes and Cancer, 5(5-6), 212-225. doi:10.18632/genesandcancer.20DOI: 10.18632/genesandcancer.20
Molecular Mechanisms Involved in the Transition of Prostate Cancer Cells from Androgen Dependant to Castration Resistant State (Journal article)
Molecular Mechanisms Involved in the Transition of Prostate Cancer Cells from Androgen Dependant to Castration Resistant State (n.d.). Journal of Andrology and Gynaecology, 2(3). doi:10.13188/2332-3442.1000017DOI: 10.13188/2332-3442.1000017
The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer. (Journal article)
Seyed Forootan, F., Seyed Forootan, S., Malki, M. I., Chen, D., Li, G., Lin, K., . . . Ke, Y. (2014). The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.. International Journal of Oncology, 44(1), 265-275.
2013
A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells. (Journal article)
Bao, Z., Malki, M. I., Forootan, S. S., Adamson, J., Forootan, F. S., Chen, D., . . . Ke, Y. (2013). A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.. Genes & cancer, 4(7-8), 297-314. doi:10.1177/1947601913499155DOI: 10.1177/1947601913499155
2012
Splice variant <i>PRKC</i>-ζ-<i><sub>PrC</sub></i> is a novel biomarker of human prostate cancer (Journal article)
Yao, S., Ireland, S. J., Bee, A., Beesley, C., Forootan, S. S., Dodson, A., . . . Foster, C. S. (2012). Splice variant <i>PRKC</i>-ζ-<i><sub>PrC</sub></i> is a novel biomarker of human prostate cancer. BRITISH JOURNAL OF CANCER, 107(2), 388-399. doi:10.1038/bjc.2012.162DOI: 10.1038/bjc.2012.162
2011
siRNA Knockdown of Ribosomal Protein Gene <i>RPL19</i> Abrogates the Aggressive Phenotype of Human Prostate Cancer (Journal article)
Bee, A., Brewer, D., Beesley, C., Dodson, A., Forootan, S., Dickinson, T., . . . Foster, C. S. (2011). siRNA Knockdown of Ribosomal Protein Gene <i>RPL19</i> Abrogates the Aggressive Phenotype of Human Prostate Cancer. PLOS ONE, 6(7). doi:10.1371/journal.pone.0022672DOI: 10.1371/journal.pone.0022672
Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression (Journal article)
Zhang, Y., Forootan, S. S., Kamalian, L., Bao, Z. Z., Malki, M. I., Foster, C. S., & Ke, Y. (2011). Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression. INTERNATIONAL JOURNAL OF ONCOLOGY, 38(4), 1083-1091. doi:10.3892/ijo.2011.932DOI: 10.3892/ijo.2011.932
Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin (Journal article)
Zhang, Y., Forootan, S. S., Kamalian, L., Bao, Z. Z., Malki, M. I., Foster, C. S., & Ke, Y. (2011). Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin. Int J Oncol, 38(4), 1083-1091.
2010
Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression (Journal article)
Kamalian, L., Forootan, S. S., Bao, Z. Z., Zhang, Y., Gosney, J. R., Foster, C. S., & Ke, Y. (2010). Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression. INTERNATIONAL JOURNAL OF ONCOLOGY, 37(3), 595-603. doi:10.3892/ijo_00000708DOI: 10.3892/ijo_00000708
2009
Atelocollagen-delivered siRNA targeting the <i>FABP5</i> gene as an experimental therapy for prostate cancer in mouse xenografts (Journal article)
Forootan, S. S., Bao, Z. Z., Forootan, F. S., Kamalian, L., Zhang, Y., Bee, A., . . . Ke, Y. (2010). Atelocollagen-delivered siRNA targeting the <i>FABP5</i> gene as an experimental therapy for prostate cancer in mouse xenografts. INTERNATIONAL JOURNAL OF ONCOLOGY, 36(1), 69-76. doi:10.3892/ijo_00000476DOI: 10.3892/ijo_00000476
2008
Increased expression of Id family proteins in small cell lung cancer and its prognostic significance (Journal article)
Kamalian, L., Gosney, J. R., Forootan, S. S., Foster, C. S., Bao, Z. Z., Beesley, C., & Ke, Y. (2008). Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. CLINICAL CANCER RESEARCH, 14(8), 2318-2325. doi:10.1158/1078-0432.CCR-07-4716DOI: 10.1158/1078-0432.CCR-07-4716
Expression of the cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression (Journal article)
Morgan, E. A., Forootan, S. S., Adamson, J., Foster, C. S., Fujii, H., Igarashi, M., . . . Ke, Y. (2008). Expression of the cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression. International Journal of Oncology, 32(4), 767-775.
2007
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. (Journal article)
Forootan, S. S., Wong, Y. -C., Dodson, A., Wang, X., Lin, K., Smith, P. H., . . . Ke, Y. (2007). Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.. Human pathology, 38(9), 1321-1329. doi:10.1016/j.humpath.2007.02.011DOI: 10.1016/j.humpath.2007.02.011
Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients (Journal article)
Zhang, Y., Forootan, S. S., Liu, D., Barraclough, R., Foster, C., Rudland, P. S., & Ke, Y. (2007). Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. PROSTATE CANCER AND PROSTATIC DISEASES, 10(3), 293-300. doi:10.1038/sj.pcan.4500960DOI: 10.1038/sj.pcan.4500960
2006
Prognostic significance of osteopontin expression in human prostate cancer. (Journal article)
Forootan, S. S., Foster, C. S., Aachi, V. R., Adamson, J., Smith, P. H., Lin, K., & Ke, Y. (2006). Prognostic significance of osteopontin expression in human prostate cancer.. International journal of cancer, 118(9), 2255-2261. doi:10.1002/ijc.21619DOI: 10.1002/ijc.21619
Ribosomal protein L19 is a prognostic marker for human prostate cancer (Journal article)
Bee, A., Ke, Y. Q., Forootan, S., Lin, K., Beesley, C., Forrest, S. E., & Foster, C. S. (2006). Ribosomal protein L19 is a prognostic marker for human prostate cancer. CLINICAL CANCER RESEARCH, 12(7), 2061-2065. doi:10.1158/1078-0432.CCR-05-2445DOI: 10.1158/1078-0432.CCR-05-2445
2000
Basic fibroblast growth factor and angiogenesis in squamous carcinoma of the tongue (Journal article)
Forootan, S. S., Ke, Y., Jones, A. S., & Helliwell, T. R. (2000). Basic fibroblast growth factor and angiogenesis in squamous carcinoma of the tongue. ORAL ONCOLOGY, 36(5), 437-443. doi:10.1016/S1368-8375(00)00032-4DOI: 10.1016/S1368-8375(00)00032-4
1999
Neoangiogenesis and squamous cell carcinoma of the tongue (Journal article)
Forootan, S. S., Jones, A. S., & Helliwell, T. R. (1999). Neoangiogenesis and squamous cell carcinoma of the tongue. CANCER DETECTION AND PREVENTION, 23(2), 137-146. doi:10.1046/j.1525-1500.1999.09911.xDOI: 10.1046/j.1525-1500.1999.09911.x
1997
Tumour angiogenesis and prognosis (Journal article)
Helliwell, T. R., & Forootan, S. S. (1997). Tumour angiogenesis and prognosis. HISTOPATHOLOGY, 31(4), 388-389. Retrieved from https://www.webofscience.com/
